VHH (Nanobody) is a small, stable antibody derived from camelid heavy-chain-only antibody. Its size and stability make it valuable for disease diagnosis and treatment. VHH's small size allows easier transportation through physiological barriers and cost-effective large-scale manufacturing.

iReal-IHC antibodies are designed for optimized use in pathological and covers a variety of research interests including oncology, tumor microenvironment, immunology, exosome, cardiovascular disease, and neurodegenerative disorders.